Strepsils with Warming Effect - instructions for use, doses, side effects, contraindications

Excipients: tartaric acid 26 mg, anthocyanin (E163) dye 3.46 mg, plum flavor 9.1 mg, cream flavor 4.37 mg, flavoring with warming effect 0.52 mg, flavoring flavor ginger 2.08 mg,triglycerides medium-chain 0.79 mg; sugar syrup [sucrose, water] and 1384 mg Dextrose liquid [dextrose, oligo- and polysaccharides] (liquid glucose) 1102 mg (to give tablets weighing 2.6 g).

Description:

Round tablets from red to violet color with engraved letters S with 2 sides of the pill. Allowed white coating, uneven staining, the presence of air bubbles in the caramel mass and a slight uneven edges.

Pharmacotherapeutic group:Antiseptic

ATX: & nbsp

R.02.A.A Antiseptics

Pharmacodynamics:

The drug has an antiseptic effect, is active against a wide range of Gram-positive and Gram-negative microorganisms in vitro, has antimycotic action.

Indications:

Symptomatic treatment of pain in the oral cavity, throat, larynx in infectious and inflammatory diseases: tonsillitis, pharyngitis, laryngitis (including professional character - the teachers, speakers, chemical and coal industries employees), hoarseness, inflammation of the oral mucosa and gums ( aphthous stomatitis, gingivitis, thrush).

Contraindications:

Hypersensitivity to the components of the drug; children's age (up to 6 years).

Carefully:

Pregnancy, the period of breastfeeding, bronchial asthma.

Pregnancy and lactation:

During pregnancy and during breastfeeding, the drug is used only if the intended benefit to the mother exceeds the potential risk to the fetus and the baby. For the duration of treatment, breastfeeding should be discontinued.

Dosing and Administration:

Locally. Recommended for adults and children over 6 years. To dissolve one tablet every 2-3 hours. Adults and children over 12 years of age should not take more than 12 tablets within 24 hours. Children from 6 to 12 years old do not take more than 8 tablets in 24 hours. Do not exceed the indicated dose.

The course of treatment is 3 days. If symptoms persist for more than 3 days, consult a doctor.

Side effects:

Allergic reactions: a rash, a burning sensation and tingling in the throat, hypersensitivity reactions to the drug components are possible.

If any of the side effects indicated in the manual are aggravated, or any other side effects not indicated in the instructions are noted, you should inform the doctor immediately.

Overdose:

Symptoms: a possible overdose can lead to discomfort from the gastrointestinal tract - nausea.

Treatment: symptomatic under the supervision of a doctor.

Interaction:

Clinically significant interactions with other drugs have not been reported. The simultaneous use of the drug with other local antimicrobial agents is possible.

Special instructions:

Do not use the drug in the presence of increased individual sensitivity to any component that is part of the drug. Patients with diabetes should take into account that each tablet contains about 2.6 g of sugar, which corresponds to 0.22 XE (bread units).

Effect on the ability to drive transp. cf. and fur:

The drug does not affect the ability to drive vehicles and mechanisms, as well as to engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

Form release / dosage:

Lozenges.

Packaging:

For 8 or 12 tablets in a blister of PVC / PVDC / aluminum foil. For 1, 2 or 3 blisters are put in a cardboard box, or in a metal box, or in a package of packaging laminated foil together with instructions for use.

10 tablets for resorption in a polypropylene tube with a polypropylene cover, which provides control of the first opening, with a desiccant. Instructions for use are under the label.

Storage conditions:

Store in a dry place at a temperature of no higher than 25 ° C.

Keep the drug out of the reach of children.

Shelf life:

2 years.

Do not use after the expiration date.

Tuba: use within 3 months after opening.

Terms of leave from pharmacies:Without recipe

Registration number:LP-001623

Date of registration:03.04.2012

The owner of the registration certificate:Rekitt Benckiser Helsar International Ltd.Rekitt Benckiser Helsar International Ltd. United Kingdom

Manufacturer: & nbsp

RECKITT BENCKISER HEALTHCARE INTERNATIONAL, Ltd. United Kingdom

Representation: & nbspREKITT BENKIZER HELSKER LTD. REKITT BENKIZER HELSKER LTD. United Kingdom

Information update date: & nbsp30.08.2015

Illustrated instructions

Instructions

Strepsils® with Warming Effect (Strepsils® with warming effect)